Abstract
Some novel pyrazoline derivatives bearing thiazole and thiophene moieties have been efficiently synthesized and characterized. The synthetic approach involves condensation of 5-acetylthiazole 1 with 2-formyl thiophene 2 followed by heterocyclization of the produced chalcone 3 with hydrazine and thiosemicarbazide under different conditions to give selectively 1-substituted-3-(thiazol-5-yl)-5-(thiophen-2-yl)pyrazolines 4–6 and 8 in high yields. Heterocyclization of 1-thicarbomylpyrazoline 8 with 3-chloro-2,4-pentanedione, phenacyl bromide and hydrazonoyl bromides in boiling ethanol and TEA results in the respective 1-(thiazol-2-yl)-3-(thiazol-5-yl)-5-(thiophen-2-yl)pyrazolines 11, 12, and 14a–14f. Anticancer activity of the novel 1,3,5-trisubstituted pyrazolines has been evaluated, against breast (MCF-7), liver (HepG2), and colon (HCT-116) cancer cell lines, as well as epithelial (REP1) normal cell line. Among the synthesized pyrazolines, compounds 8, 14a, and 14f demonstrate the highest anticancer activity with IC50 values of 1.83, 5.47, and 11.43 µM, respectively, and presenting no evidence of human toxicity.
Similar content being viewed by others
REFERENCES
Albuquerque, H.M.T., Santos, C.M.M., Cavaleiro, J.A.S., and Silva, A.M.S., Curr. Org. Chem., 2014, vol. 18, p. 2750. https://doi.org/10.2174/1385272819666141013224253
Mathew, B., Haridas, A., Ucar, G., Baysal, I., Jay, M., Mathew, G.E., Lakshmanan, B., and Jayaprakash, V., ChemMedChem., 2016, vol. 11, p.1161. https://doi.org/10.1002/cmdc.201600122
Rathish, I.G., Javed, K., Ahmad, S., Bano, S., Alam, M.S., Pillai, K.K., Singh, S., and Bagchi, V., Bioorg. Med. Chem. Lett., 2009, vol.19, p. 255. https://doi.org/10.1016/j.bmcl.2008.10.105
Bondock, S. and Fouda, A.M., Synth. Commun., 2018, vol. 48, p. 561. https://doi.org/10.1080/00397911.2017.1412465
Bondock, S. and Nasr, T., Russ. J. Gen. Chem., 2021, vol. 91, p. 488. https://doi.org/10.1134/S1070363221030178
Aggarwal, S., Paliwal, D., Kaushik, D., Gupta, G.K., and Kumar, A., Lett. Org. Chem., 2019, vol. 16, p. 807. https://doi.org/10.2174/1570178616666190212145754
Manetti, F., Brullo, C., Magnani, M., Mosci, F., Chelli, B., Crespan, E., Schenone, S., Naldini, A., Bruno, O., Trincavelli, M. L., Maga, G., Carraro, F., Martini, C., Bondavalli, F., and Botta, M., J. Med. Chem., 2008, vol. 51, p. 1252. https://doi.org/10.1021/jm701240c
Rostom, S.A.F., Badr, M.H., Abd El Razik, H.A., Ashour, H.M.A., and Abdel Wahab, A.E, Arch. Pharm. Chem. Life Sci., 2011, vol. 344, p. 572. https://doi.org/10.1002/ardp.201100077
Schenone, S., Bruno, O., Ranise, A., Bondavalli, F., Brullo, C., Fossa, P., Mosti, L., Menozzi, G., Carraro, F., Naldini, A., Bernini, C., Manetti, F., and Botta, M., Bioorg. Med. Chem. Lett., 2004, vol. 14, p. 2511. https://doi.org/10.1016/j.bmcl.2004.03.013
Zhu, G.D., Gong, J., Gandhi, V.B., Woods, K., Luo, Y., Liu, X., Guan, R., Kinghofer, V., Johson, E.F., Stoll, V.S., Mamo, M., Li, Q., Rosenberg, S.H., and Giranda, V.L., Bioorg. Med. Chem., 2007, vol. 15, p. 2441. https://doi.org/10.1016/j.bmc.2007.01.010
Bhat, B.A., Dhar, K.L., Puri, S.C., Saxena, A.K., Shanmugavel, M., and Qazi, G.N., Bioorg. Med. Chem. Lett., 2005, vol. 15, p. 3177. https://doi.org/10.1016/j.bmcl.2005.03.121
Matiadis, D. and Sagnou, M., Int. J. Mol. Sci., 2020, vol. 21, p. 5507. https://doi.org/10.3390/ijms21155507
Morigi, R., Locatelli, A., Leoni, A., and Rambaldi, M., Recent Pat. Anticancer Drug Discov., 2015, vol. 10, p. 280. https://doi.org/10.2174/1574892810666150708110432
Lu, Y., Li, C.-M., Wang, Z., Ross, C.R., Chen, J., Dalton, J.T., Li, W., and Miller, D.D., J. Med. Chem., 2009, vol. 52, p. 1701. https://doi.org/10.1021/jm801449a
Bondock, S., Alqahtani, S., and Fouda, A.M., J. Heterocycl. Chem., 2021, vol. 58, p. 56. https://doi.org/10.1002/jhet.4148
Ramadan, A.M., Elsamra, R.M.I., and Bondock, S., Appl. Organometal. Chem., 2021, vol. 35, p. e6102. https://doi.org/10.1002/aoc.6102
Bondock, S., Nasr, T., and Alqahtani, S., Chemistry Select, 2020, vol. 5, p. 12087. https://doi.org/10.1002/slct.202002912
Bondock, S., Alqahtani, S., and Fouda, A.M., Synth. Commun., 2019, vol. 49, p. 2188. https://doi.org/10.1080/00397911.2019.1616759
Bondock, S. and Gieman, H., Res. Chem. Intermed., 2015, vol. 41, p. 8381. https://doi.org/10.1007/s11164-014-1899-8
Beloglazkina, E.K., Korablina, D.D., Vorozhtsov, N.I., Sviridova, L.A., Moiseeva, A.A., Skvortsov, D.A., Rybakov, V.B., Majouga, A.G., and Zyk, N.V., Arab. J. Chem., 2019, vol. 12, p. 1050. https://doi.org/10.1016/j.arabjc.2017.01.005
Mansour, E., Aboelnaga, A.; Nassar, E.M., and Elewa, S.I., Synth. Commun., 2020, vol. 50, p. 368. https://doi.org/10.1080/00397911.2019.1695839
Shawali, A.S. and Abdelhamid, A.O., Bull. Chem. Soc. Jpn., 1976, vol. 49, p. 321. https://doi.org/10.1246/bcsj.49.321
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R., J. Natl. Cancer Inst., 1990, vol. 82, p. 1107. https://doi.org/10.1093/jnci/82.13.1107
Vichai, V. and Kirtikara, K., Nat. Protoc., 2006, vol. 1, p. 1112. https://doi.org/10.1038/nprot.2006.179
Funding
The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through a research group project under grant no. RGP.1/32/42. The authors would like to express their gratitude to King Khalid University, Abha, Saudi Arabia for providing administrative and technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Rights and permissions
About this article
Cite this article
Bondock, S., Albormani, O. & Fouda, A.M. Facile Synthesis and Anticancer Evaluation of Novel 1-(Thiazol-2-yl)-3-(thiazol-5-yl)-5-(thiophen-2-yl) Pyrazolines. Russ J Gen Chem 92, 1098–1108 (2022). https://doi.org/10.1134/S1070363222060226
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363222060226